Pacritinib Targets IRAK1 and Shows Synergy with HDAC and BET Inhibitors in Acute Myeloid Leukemia

被引：4
|
作者：
Puri, Alka [1 ]
Mahmood, Shawn [1 ]
Maertens, Bernadette [1 ]
Davare, Monika [2 ]
Kurtz, Stephen E. [1 ]
Tognon, Cristina E. [1 ,3 ]
Eden, Christopher O. [1 ]
Elferich, Johannes [4 ]
Shinde, Ujwal [4 ]
Druker, Brian J. [1 ,3 ]
Singer, Jack W. [5 ]
Agarwal, Anupriya [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR USA
[2] Oregon Hlth & Sci Univ, Pape Pediat Res Inst, Dept Pediat, Portland, OR USA
[3] Howard Hughes Med Inst, Portland, OR USA
[4] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR USA
[5] CTI BioPharma Corp, Seattle, WA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3514.3514
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3514
引用
收藏
页数：5
相关论文
共 50 条
  • [41] HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b
    Lepore, Ilaria
    Dell'Aversana, Carmela
    Pilyugin, Maxim
    Conte, Mariarosaria
    Nebbioso, Angela
    De Bellis, Floriana
    Tambaro, Francesco P.
    Izzo, Tiziana
    Garcia-Manero, Guillermo
    Ferrara, Felicetto
    Irminger-Finger, Irmgard
    Altucci, Lucia
    PLOS ONE, 2013, 8 (12):
  • [42] Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In Vivo
    Jiang, Yuqi
    Xu, Jie
    Yue, Kairui
    Huang, Chao
    Qin, Mengting
    Chi, Dongyu
    Yu, Qixin
    Zhu, Yue
    Hou, Xiaohan
    Xu, Tongqiang
    Li, Min
    Chou, C. James
    Li, Xiaoyang
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (01) : 285 - 302
  • [43] New Allosteric Inhibitors of Mutant IDH1 in Acute Myeloid Leukemia
    Okoye-Okafor, Ujunwa Cynthia
    Bartholdy, Boris
    Cartier, Jessy
    Gao, Enoch
    Pietrak, Beth
    Rendina, Alan R.
    Rominger, Cynthia
    Quinn, Chad
    Smallwood, Angela
    Wiggall, Ken
    Reif, Alexander
    Schmidt, Stan
    Qi, Hongwei
    Zhao, Huizhen
    Joberty, Gerard
    Faelth-Savitski, Maria
    Bantscheff, Marcus
    Drewes, Gerard
    Duraiswami, Chaya
    Brady, Pat
    Narayanagari, Swathi-rao
    Antony-Debre, Ileana
    Mitchell, Kelly
    Carvajal, Luis
    Wang, Heng Rui
    Barreyro, Laura
    Kao, Yun-Ruei
    Christopeit, Maximilian
    Paietta, Elisabeth
    Makishima, Hideki
    Will, Britta
    Concha, Nestor
    Adams, Nicholas
    Schwartz, Benjamin
    McCabe, Michael T.
    Maciejewski, Jaroslaw P.
    Verma, Amit
    Steidl, Ulrich
    BLOOD, 2015, 126 (23)
  • [44] New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
    Ujunwa C Okoye-Okafor
    Boris Bartholdy
    Jessy Cartier
    Enoch N Gao
    Beth Pietrak
    Alan R Rendina
    Cynthia Rominger
    Chad Quinn
    Angela Smallwood
    Kenneth J Wiggall
    Alexander J Reif
    Stanley J Schmidt
    Hongwei Qi
    Huizhen Zhao
    Gerard Joberty
    Maria Faelth-Savitski
    Marcus Bantscheff
    Gerard Drewes
    Chaya Duraiswami
    Pat Brady
    Arthur Groy
    Swathi-Rao Narayanagari
    Iléana Antony-Debre
    Kelly Mitchell
    Heng Rui Wang
    Yun-Ruei Kao
    Maximilian Christopeit
    Luis Carvajal
    Laura Barreyro
    Elisabeth Paietta
    Hideki Makishima
    Britta Will
    Nestor Concha
    Nicholas D Adams
    Benjamin Schwartz
    Michael T McCabe
    Jaroslav Maciejewski
    Amit Verma
    Ulrich Steidl
    Nature Chemical Biology, 2015, 11 : 878 - 886
  • [45] New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
    Okoye-Okafor, Ujunwa C.
    Bartholdy, Boris
    Cartier, Jessy
    Gao, Enoch N.
    Pietrak, Beth
    Rendina, Alan R.
    Rominger, Cynthia
    Quinn, Chad
    Smallwood, Angela
    Wiggall, Kenneth J.
    Reif, Alexander J.
    Schmidt, Stanley J.
    Qi, Hongwei
    Zhao, Huizhen
    Joberty, Gerard
    Faelth-Savitski, Maria
    Bantscheff, Marcus
    Drewes, Gerard
    Duraiswami, Chaya
    Brady, Pat
    Groy, Arthur
    Narayanagari, Swathi-Rao
    Antony-Debre, Ileana
    Mitchell, Kelly
    Wang, Heng Rui
    Kao, Yun-Ruei
    Christopeit, Maximilian
    Carvajal, Luis
    Barreyro, Laura
    Paietta, Elisabeth
    Makishima, Hideki
    Will, Britta
    Concha, Nestor
    Adams, Nicholas D.
    Schwartz, Benjamin
    McCabe, Michael T.
    Maciejewski, Jaroslav
    Verma, Amit
    Steidl, Ulrich
    NATURE CHEMICAL BIOLOGY, 2015, 11 (11) : 878 - U107
  • [46] HDAC and LSD1 Inhibitors Synergize to Induce Cell Death in Acute Leukemia Cells
    Ramirez, Lorimar
    Singh, Melissa
    Chandra, Joya
    BLOOD, 2011, 118 (21) : 620 - 620
  • [47] Analysis of the transcription factor, DP-1, in acute myeloid leukemia shows no functional abnormalities
    Williams, CD
    Sorensen, TS
    LaThangue, NB
    Linch, DC
    Thomas, NSB
    BLOOD, 1995, 86 (10) : 2974 - 2974
  • [48] Novel Fusion Gene Aven-NUTM1 Induces Mice Myeloid Leukemia Vulnerable to HDAC Inhibitors
    Dan, Yuqing
    Ren, Ruibao
    Li, Donghe
    Liu, Ping
    BLOOD, 2023, 142
  • [49] RUNX1 NEOANTIGENS AS TARGETS FOR TCR GENE THERAPY IN ACUTE MYELOID LEUKEMIA
    Struckman, N.
    De Jong, R.
    Van der Lee, D.
    Van Veelen, P.
    Falkenburg, J. H. F.
    Griffioen, M.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A24 - A24
  • [50] Novel and selective inhibitors of histone deacetylases (HDAC) 1 and 2 significantly enhance the activity of the DNA methyltransferase inhibitor azacitidine in acute myeloid leukemia (AML)
    Min, Chengyin
    Quayle, Steven N.
    Tamang, David
    Jones, Simon S.
    Yang, Min
    CANCER RESEARCH, 2015, 75
12345